Applications now open for the 2024 Golden Ticket competition

As part of our commitment to accelerating transformative research and development, we’re excited to announce that our annual Golden Ticket competition is now open! Through our continued partnership with BioLabs, we’re delighted to be offering the brightest minds in biotech a chance to secure free laboratory space at a cutting-edge facility in the heart of Paris, France, close to Notre-Dame, at Paris Hopital Hotel Dieu, AP-HP.

Ipsen is a founding sponsor of BioLabs-Hôtel Dieu, which is a life science entrepreneurial community focussed on fuelling the next generation of innovators and life-saving technologies. Participation in this Golden Ticket competition in no way restricts your opportunity to partner/collaborate or seek funding from other routes.

Who should apply?

We believe that supporting early innovation is crucial to advancing the life-changing therapies of the future. We also believe that great partnerships create great possibilities, which is why we’re opening this opportunity up to all biotech start-up companies working across our three areas of focus for research and development. We’re encouraging applications from those working with:

• Innovative therapeutic approaches in rare diseases, neuroscience or oncology
• Novel biomarker discovery platforms in rare diseases, neuroscience or oncology
• Innovative technology platforms, including targeted delivery of therapeutics

Apply now!

Visit the BioLabs website here to submit your application before the closing deadline on April 30^th 2024.

The Golden Ticket competition is subject to specific terms and conditions available on the BioLabs website. By submitting your application to the Golden Ticket competition you confirm that you have read and agree to be bound by such terms and conditions.

Any questions?

If you would like more information about the competition, please reach out by emailing one of our competition ambassadors below: